OpenAI has launched the Rosalind Academic Plan, a new programme offering eligible academic research laboratories at US universities up to 30 complimentary ChatGPT Business Standard seats for 12 months, alongside access to its specialised life-sciences AI model, GPT-Rosalind. Announced on October 15, 2026, the initiative is designed to help academic scientists use advanced AI tools for biological research, drug discovery, genomics and other scientific applications without paying the standard seat subscription cost during the promotional period.
The programme combines ChatGPT and Codex access with GPT-Rosalind, a model developed for complex life-sciences research and scientific workflows. However, access is not automatic. Research laboratories must pass OpenAI’s eligibility and trusted-access reviews, and the offer is currently restricted to university-affiliated academic labs in the United States. The plan also excludes API access and API credits, meaning researchers seeking to build external applications or API-powered systems will need a separate access arrangement.
Key Takeaways
- New programme: OpenAI introduced the Rosalind Academic Plan on October 15, 2026.
- Free seats: Eligible labs can receive up to 30 ChatGPT Business Standard seats at no cost for 12 months.
- Specialised AI: Approved researchers can access GPT-Rosalind for life-sciences research.
- US-only eligibility: The offer is currently limited to academic research labs at US universities.
- Research applications: Potential uses include drug discovery, protein design, genomics, diagnostics, vaccines and scientific literature analysis.
- Approval required: A principal investigator (PI) or designated lab lead must apply, and the lab must pass verification.
- No API credits: The academic offer does not include GPT-Rosalind API access or API usage credits.
- Data handling: Researchers should review the plan’s workspace and data-retention terms before uploading sensitive research information.
What Is OpenAI’s Rosalind Academic Plan?
The Rosalind Academic Plan is an academic-access programme intended to make OpenAI’s specialised scientific AI tools more accessible to university research laboratories.
Rather than offering a discount to individual students or researchers, OpenAI provides access through an approved lab workspace. A principal investigator or designated lab lead applies for the programme, oversees the workspace and manages access for eligible members.
Once approved, the lab can receive up to 30 ChatGPT Business Standard seats for 12 months. Those seats include ChatGPT and Codex, subject to their applicable usage limits. Access to GPT-Rosalind is separately subject to trusted-access approval and activation.
The distinction between the standard seats and the specialised model matters. Receiving a complimentary ChatGPT Business workspace does not, by itself, guarantee GPT-Rosalind access. Researchers must complete the required review and follow the activation process.
The programme also has a defined scope. It is intended for academic research rather than general consumer use, and it does not automatically extend to commercial biotechnology companies, independent researchers without an eligible university lab or university labs outside the United States.
What does the plan include?
| Feature | What eligible labs receive |
|---|---|
| ChatGPT Business Standard | Up to 30 complimentary seats |
| Promotional period | Up to 12 months |
| GPT-Rosalind | Access after trusted-access approval |
| Codex | Included with Standard seats, subject to usage limits |
| Research workspace | Shared environment managed by the lab lead |
| API access | Not included |
| API credits | Not included |
| Geographic eligibility | Academic labs at US universities |
The offer is subject to eligibility, approval, activation and the programme’s terms. The complimentary period and seat limits should be checked in the approved offer before workspace setup.
What Is GPT-Rosalind?
GPT-Rosalind is OpenAI’s specialised model for life-sciences research. It is designed to help scientists synthesise evidence, reason through complex biological questions and coordinate workflows involving scientific tools, literature, databases and research data.
General-purpose AI assistants can help summarise papers, explain concepts and draft code. A model designed for life sciences aims to provide more specialised support for research tasks in which biological relationships, molecular data and experimental context matter.
GPT-Rosalind can support activities including literature synthesis, target research, genomics and sequencing analysis, protein and sequence analysis, medicinal chemistry, wet-lab troubleshooting and experiment planning.
The Rosalind Workbench and associated tools are intended to help researchers connect model reasoning with specialised scientific workflows. This can reduce the friction involved in moving between scientific literature, datasets, analysis code and other research resources.
However, AI-generated research suggestions remain hypotheses and analytical assistance, not automatically validated scientific results. Researchers must independently evaluate the evidence, check calculations, validate proposed methods and conduct appropriate experiments before relying on a finding.
How OpenAI Plans to Support Drug Discovery
One of the programme’s central applications is research into potential medicines and biological therapies.
Drug discovery involves identifying a biological target, finding candidate molecules that may affect it, assessing their activity and safety, and determining whether they merit further testing. The process can require extensive literature review, molecular analysis, computational modelling and laboratory experimentation.
AI tools can assist researchers at several stages by organising evidence, comparing candidate molecules, suggesting analyses and helping develop computational workflows.
Drug and protein design
Researchers may use GPT-Rosalind to investigate candidate drugs, therapeutic proteins, peptides and enzymes. It can help examine questions about molecular interactions, selectivity, stability and potential suitability for further development.
These capabilities may help scientists explore more candidates or organise information more efficiently. They do not replace the experimental work required to establish whether a molecule is effective, safe or suitable for clinical development.
Genomics and genetic therapies
The model is also designed to support research involving genomic data, sequencing analysis and genetic or RNA-based therapies.
Potential applications include investigating biological mechanisms, studying gene expression and exploring approaches to correcting genetic defects. AI-assisted analysis can help researchers connect findings across scientific papers and datasets, although results must be checked against validated methods and appropriate controls.
Diagnostics and disease monitoring
Another research area involves identifying molecular signatures associated with disease and investigating diagnostic approaches, including liquid biopsies and other minimally invasive tests.
AI may help researchers compare evidence across studies, identify candidate biomarkers and organise analytical workflows. Whether a proposed biomarker can reliably detect disease or monitor treatment response must still be established through appropriate validation.
Vaccines, Antimicrobial Resistance and Other Research Areas
The programme extends beyond drug discovery into other areas of biological and medical research.
For vaccine and immunology research, GPT-Rosalind can help scientists examine host-pathogen interactions, investigate immune responses and evaluate evidence related to potential vaccine approaches.
Antimicrobial resistance is another important area. Researchers could use the tools to study how microorganisms resist antibiotics, antivirals and antifungals, or to organise research into treatments for resistant infections.
The model is also intended to support agriculture and animal health. Applications may include investigating crop resilience, plant disease, animal health and biological factors that influence food production.
Ecology and conservation research could benefit from assistance with biodiversity studies, species interactions, environmental exposures and ecosystem change.
These use cases illustrate the breadth of the programme. OpenAI is positioning GPT-Rosalind as a tool for scientific discovery across multiple life-sciences disciplines, rather than as a system limited to pharmaceutical companies or medical research.
Nevertheless, the model’s practical value will depend on the quality of the underlying data, the researcher’s expertise, the available scientific tools and the validation of its outputs.
Who Is Eligible for the Rosalind Academic Plan?
The programme is currently available only to academic research labs at US universities. A principal investigator or designated lab lead must submit the application on behalf of the lab.
Researchers should not assume that an institutional email address alone establishes eligibility. OpenAI reviews the university, laboratory, applicant’s role and intended research use before granting access.
| Requirement | What applicants need |
|---|---|
| Institution | Eligible US university |
| Applicant | Principal investigator or designated lab lead |
| Verification | Institutional email and identity checks |
| Research information | Lab details, research focus and intended use |
| Lab oversight | An identified lead and designated safety contact |
| Membership | Up to 30 eligible lab members |
| Model access | Separate trusted-access approval for GPT-Rosalind |
Labs at universities without an existing OpenAI Enterprise agreement can apply through the academic-lab application process. If a university already has an Enterprise agreement, the lab must follow the university’s established access process instead.
The programme is not the same as ChatGPT Edu or OpenAI’s separate ChatGPT for Academic Researchers programme. Approval under one programme does not automatically provide access to the Rosalind Academic Plan.
How Academic Labs Can Apply
OpenAI has opened applications for eligible laboratories. The process is designed to verify both the institution and the research context before access is granted.
The PI or lab lead should first sign in with the ChatGPT account associated with their institutional university email address. The applicant then provides information about the university, department, lab, research focus, intended use and proposed members.
OpenAI also requires verification of the applicant’s identity and authority to oversee lab access. The review includes the laboratory’s institutional affiliation, research activities and arrangements for responsible use.
After approval, the lab lead receives instructions for activating the offer and setting up the workspace. They can then add eligible members and enable GPT-Rosalind access for approved users.
Researchers should check the promotional period, seat count and applicable terms before completing setup. OpenAI says a payment card is required during setup, even though the eligible seats are complimentary during the stated period.
The plan supports a maximum of 30 seats in one workspace. Laboratories that need more seats should contact OpenAI Support to discuss their requirements rather than assume they can extend the complimentary allocation by creating additional workspaces.
Data Privacy and Research Safety
Research data can include unpublished findings, sensitive biological information, confidential collaborations and other material that universities need to protect. For this reason, researchers should understand the plan’s data-handling arrangements before uploading information.
OpenAI states that research data shared through the Rosalind Academic Plan is not used to train its models by default. However, the academic offer does not automatically include every protection available under other institutional arrangements.
The Help Center specifies that standard data-retention arrangements apply by default and that Zero Data Retention is not available under this offer. Depending on the workspace settings, applicable law and institutional arrangements, an administrator may be able to access, export, retain or delete workspace data.
Researchers should therefore review university policies, workspace controls and applicable data-handling terms before adding confidential or regulated research data. Sensitive datasets should not be uploaded simply because a lab has received complimentary access.
OpenAI also applies trusted-access checks intended to support legitimate scientific research while managing risks associated with sensitive biological work. Verification and monitoring continue after activation, and researchers may be asked to clarify their intended use.
These measures are designed to distinguish authorised scientific research from potentially harmful misuse, but they do not eliminate the need for institutional oversight and established biosafety procedures.
What the Plan Means for Academic Research
The Rosalind Academic Plan could reduce one barrier to using advanced AI in academic laboratories: the recurring cost of providing access to multiple researchers.
A lab with up to 30 members can use a shared workspace to review scientific literature, work with research data and develop analysis code. This may make it easier for teams to experiment with AI-assisted workflows without paying standard seat fees during the complimentary period.
The programme could be particularly useful for labs that lack dedicated AI engineering teams. Researchers may be able to use the tools to accelerate preliminary analysis, organise complex evidence or develop computational methods before deciding whether a larger investment is justified.
However, the benefits will vary by discipline and workflow. Some projects depend heavily on specialised instruments, clinical datasets or wet-lab experimentation that AI cannot replace. Others may require API integrations or infrastructure beyond what the academic offer provides.
The 12-month limit also matters. Labs should consider how they would sustain access after the complimentary period ends and avoid designing critical research operations around a benefit whose future cost has not been established in the offer.
The Bigger Picture
OpenAI’s Rosalind Academic Plan represents a targeted effort to bring specialised AI tools into academic life-sciences research. By combining complimentary ChatGPT Business seats with trusted access to GPT-Rosalind, the company is trying to help researchers use AI for complex scientific tasks without requiring every lab to fund a separate subscription immediately.
The programme’s impact will depend on whether researchers can turn AI-assisted analysis into reproducible scientific progress. Access to advanced models may help teams investigate more questions and organise evidence efficiently, but experimental validation, data governance and expert judgement remain essential. The US-only eligibility rules, approval process and absence of API access also mean the offer is not a universal solution for every research institution.
Looking Ahead
Eligible US university labs can now apply through a PI or designated lab lead, subject to OpenAI’s verification and responsible-use requirements. The next steps for approved laboratories will involve completing workspace setup, enabling access for members and establishing internal procedures for handling research data. Labs should also check their university’s existing OpenAI agreements before applying.
Over the coming months, the programme’s usefulness will be judged by how researchers integrate GPT-Rosalind into real scientific workflows. Its potential applications span drug discovery, genomics, diagnostics, vaccines, agriculture and conservation, but success will require careful evaluation of outputs and responsible research practices. The programme lowers the initial cost of access for eligible labs; it does not remove the scientific, operational or regulatory work needed to produce reliable findings.
Frequently Asked Questions
1. What is the OpenAI Rosalind Academic Plan?
It is a programme offering eligible academic research labs at US universities up to 30 complimentary ChatGPT Business Standard seats for 12 months, along with GPT-Rosalind access after trusted-access approval.
2. Is the Rosalind Academic Plan available in India?
No. The programme is currently limited to academic research labs at US universities. Labs outside the United States are not eligible for this specific academic offer.
3. Who can apply for the programme?
A principal investigator or designated lab lead at an eligible US university must apply on behalf of the laboratory. Individual lab members do not need to submit separate applications.
4. What can GPT-Rosalind help researchers do?
It is designed to support life-sciences research, including scientific literature synthesis, drug and protein design, genomics, sequencing analysis, medicinal chemistry, diagnostics, vaccine research and experiment planning.
5. Does the plan include API credits?
No. The Rosalind Academic Plan does not include API access or API credits. API access requires a separate approval and access arrangement where available.
6. Is research data used to train OpenAI’s models?
OpenAI states that research data shared through the Rosalind Academic Plan is not used to train its models by default. Researchers should still review standard data-retention arrangements and university policies before uploading sensitive information.
7. What happens after the 12-month complimentary period?
Applicants should review the terms of their accepted offer, including its end date and any charges that may apply afterward. OpenAI’s public announcement does not establish that complimentary access will continue indefinitely.
Get the day’s top stories in your inbox
One concise email. No spam, unsubscribe anytime.
